Latest News
Valero Hits Record High as Refining Margins Surge Ahead of Q3
Valero Energy (VLO) shares surged to a record close of $309.65, fueled by record-high U.S. refining margins and investor optimism about Q3 performance.
Annaly's High Dividend Faces Scrutiny Ahead of Earnings
Annaly Capital Management's 13% forward yield is under pressure as Q2 earnings approach, with dividend coverage razor-thin and market rates rising.
Enterprise Products Partners Delivers 6.5% Cash Return Ahead of Q2 Earnings
Enterprise Products Partners (EPD) delivers a 6.53% annualized cash-return rate, blending a 5.86% distribution yield with a projected 0.67% buyback yield, ahead of Q2 earnings.
Douglas Dynamics Rebounds on Margin Optimism
Shares of Douglas Dynamics (NYSE:PLOW) gained 3.7% last week, beating the Russell 2000 by 4.2 percentage points, as the market focuses on margin expansion prospects.
GameStop's eBay Stake Nearly Equals Its Own Market Cap
GameStop's 9.8% stake in eBay, valued at $4.86 billion, is nearly half its own market cap. A $1 change in eBay moves GME by 9.7 cents.
ImmunityBio Faces Key Warrant Expiry Test on July 24 After Friday Rebound
ImmunityBio (NASDAQ:IBRX) faces a crucial warrant expiry on July 24, with up to 6.4 million shares potentially exercised, testing trading liquidity after a Friday rebound.
SELLAS Life Sciences Stock Jumps 12% Ahead of Key Trial Results
SELLAS Life Sciences rose 12.3% on Friday, closing at $13.19, with a market cap discrepancy of $319 million ahead of REGAL trial results.
Synopsys Plunges 7.85% as Moonshot AI's Open-Source Chip Demo Rattles EDA Sector
Synopsys (SNPS) tumbled 7.85% on Friday, wiping out $6.27 billion in market value after Moonshot AI showcased an open-source chip design tool.
ARK Invest Boosts SpaceX Stake Amid Pre-Starship Selloff
ARK Invest increased its SpaceX holdings by 20% on Friday, acquiring 147,805 shares as the stock fell 14.7% for the week ahead of Starship's retry.
Iovance Biotherapeutics Soars 18% as Amtagvi Sales Target Nears
Iovance Biotherapeutics (IOVA) shares jumped 18% as investors focus on the upcoming sales test for Amtagvi, with second-quarter revenue guidance of $86-$88 million.
GameStop Takes 9.8% Stake in eBay, Posing Takeover Challenge
GameStop revealed a 9.8% stake in eBay, including direct voting rights, ahead of Monday's trading. The $125 offer is 11.5% above Friday's close.